Sales of cholesterol lowering drug, Crestor is raising continuosly and due to that the Q1 profit of AstraZeneca raised by 40%. Crestor is one of the most popular drug among the emerging markets. Crestor's market share amoung the cholesterol lowering statins increased to 10.3% from 8.8% in last year.

For more information, Click Here.